381 related articles for article (PubMed ID: 10781610)
1. Identification of the enzymatic active site of CD38 by site-directed mutagenesis.
Munshi C; Aarhus R; Graeff R; Walseth TF; Levitt D; Lee HC
J Biol Chem; 2000 Jul; 275(28):21566-71. PubMed ID: 10781610
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the active site of ADP-ribosyl cyclase.
Munshi C; Thiel DJ; Mathews II; Aarhus R; Walseth TF; Lee HC
J Biol Chem; 1999 Oct; 274(43):30770-7. PubMed ID: 10521467
[TBL] [Abstract][Full Text] [Related]
3. A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities.
Graeff R; Munshi C; Aarhus R; Johns M; Lee HC
J Biol Chem; 2001 Apr; 276(15):12169-73. PubMed ID: 11278881
[TBL] [Abstract][Full Text] [Related]
4. Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.
Inageda K; Takahashi K; Tokita K; Nishina H; Kanaho Y; Kukimoto I; Kontani K; Hoshino S; Katada T
J Biochem; 1995 Jan; 117(1):125-31. PubMed ID: 7775378
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity.
Graeff RM; Walseth TF; Fryxell K; Branton WD; Lee HC
J Biol Chem; 1994 Dec; 269(48):30260-7. PubMed ID: 7982936
[TBL] [Abstract][Full Text] [Related]
6. Probing Aplysia californica adenosine 5'-diphosphate ribosyl cyclase for substrate binding requirements: design of potent inhibitors.
Migaud ME; Pederick RL; Bailey VC; Potter BV
Biochemistry; 1999 Jul; 38(28):9105-14. PubMed ID: 10413485
[TBL] [Abstract][Full Text] [Related]
7. Paracrine roles of NAD+ and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts.
Franco L; Zocchi E; Usai C; Guida L; Bruzzone S; Costa A; De Flora A
J Biol Chem; 2001 Jun; 276(24):21642-8. PubMed ID: 11274199
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.
Yamamoto-Katayama S; Ariyoshi M; Ishihara K; Hirano T; Jingami H; Morikawa K
J Mol Biol; 2002 Feb; 316(3):711-23. PubMed ID: 11866528
[TBL] [Abstract][Full Text] [Related]
9. Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.
Cakir-Kiefer C; Muller-Steffner H; Schuber F
Biochem J; 2000 Jul; 349(Pt 1):203-10. PubMed ID: 10861229
[TBL] [Abstract][Full Text] [Related]
10. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
[TBL] [Abstract][Full Text] [Related]
11. The homo-dimeric form of ADP-ribosyl cyclase in solution.
Munshi C; Baumann C; Levitt D; Bloomfield VA; Lee HC
Biochim Biophys Acta; 1998 Nov; 1388(2):428-36. PubMed ID: 9858777
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity.
Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T
Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705
[TBL] [Abstract][Full Text] [Related]
13. Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38.
Tohgo A; Takasawa S; Noguchi N; Koguma T; Nata K; Sugimoto T; Furuya Y; Yonekura H; Okamoto H
J Biol Chem; 1994 Nov; 269(46):28555-7. PubMed ID: 7961800
[TBL] [Abstract][Full Text] [Related]
14. Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities.
Graeff R; Liu Q; Kriksunov IA; Hao Q; Lee HC
J Biol Chem; 2006 Sep; 281(39):28951-7. PubMed ID: 16861223
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP.
Aarhus R; Graeff RM; Dickey DM; Walseth TF; Lee HC
J Biol Chem; 1995 Dec; 270(51):30327-33. PubMed ID: 8530456
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.
Liu Q; Graeff R; Kriksunov IA; Jiang H; Zhang B; Oppenheimer N; Lin H; Potter BV; Lee HC; Hao Q
J Biol Chem; 2009 Oct; 284(40):27637-45. PubMed ID: 19640846
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38.
Augustin A; Muller-Steffner H; Schuber F
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):43-52. PubMed ID: 10600637
[TBL] [Abstract][Full Text] [Related]
18. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
[TBL] [Abstract][Full Text] [Related]
19. Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase.
Tohgo A; Munakata H; Takasawa S; Nata K; Akiyama T; Hayashi N; Okamoto H
J Biol Chem; 1997 Feb; 272(7):3879-82. PubMed ID: 9020087
[TBL] [Abstract][Full Text] [Related]
20. Dimeric and tetrameric forms of catalytically active transmembrane CD38 in transfected HeLa cells.
Bruzzone S; Guida L; Franco L; Zocchi E; Corte G; De Flora A
FEBS Lett; 1998 Aug; 433(3):275-8. PubMed ID: 9744810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
